Context Lung cancer is the leading cause of cancer death. Most patients are diagnosed with
advanced disease, resulting in a very low 5-year survival. Screening may reduce the risk of …

In the updated American Thoracic Society–European Respiratory Society classification of
the idiopathic interstitial pneumonias (IIPs), the major entities have been preserved and …

Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States in the past few years, in large part due to the results of the National Lung …

Purpose To determine the prevalence of interstitial lung abnormalities (ILAs) at initial
computed tomography (CT) examination and the rate of progression of ILAs on 2-year follow …

Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States, in large part because of the results of the National Lung Screening Trial …

Background A blood test for non-small cell lung cancer (NSCLC) may be a valuable tool for
use in a comprehensive lung cancer screening strategy. Here we report the potential of …

Lung cancer screening (LCS) with low-dose computed tomography (LDCT) was
demonstrated in the National Lung Screening Trial (NLST) to reduce mortality from the …

BACKGROUND: Despite the high survival rates reported for screening-detected cases, the
potential of screening of high-risk subjects for reducing lung cancer mortality is still …

The x-ray exposure to patients has become a major concern in computed tomography (CT)
and minimizing the radiation exposure has been one of the major efforts in the CT field. Due …

We assessed the prevalence of interstitial lung disease (ILD) in a cohort of smokers included
in a lung cancer screening trial. Two observers independently reviewed, for the presence of …